Literature DB >> 6289727

Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents.

H B Hansson, M Walder, I Juhlin.   

Abstract

A total of 199 strains of shigella (1 Shigella dysenteriae, 15 S. boydii, 47 S. flexneri, and 136 S. sonnei) isolated in Malmö, Sweden, within a 3-year period (1977 through January 1980) were tested with the agar plate dilution method for susceptibility to commonly used and newer antimicrobial agents. Mecillinam, nalidixic acid, and trimethoprim had the best in vitro activity. S. flexneri dominated among strains resistant to three or more antimicrobial agents and were less susceptible to ampicillin, chloramphenicol, and doxycycline than other types studied. Sixty-four percent of the strains were resistant to sulfamethoxazole. In vitro, a synergistic effect with trimethoprim was shown only in strains susceptible to sulfamethoxazole. The amidinopenicillin mecillinam was highly active against shigellae. When resistance occurred, it was linked to ampicillin in 17 of 18 strains. The quinolines, here represented by nalidixic acid, might be the drugs of choice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6289727      PMCID: PMC181407          DOI: 10.1128/AAC.19.2.271

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Antimicrobial resistance of Shigellae isolated in Michigan.

Authors:  R C Gordon; T R Thompson; W Carlson; J W Dyke; L I Stevens
Journal:  JAMA       Date:  1975-03-17       Impact factor: 56.272

2.  A new medium for the bacteriologic examination of stools (LSU-agar).

Authors:  I JUHLIN; C ERICSON
Journal:  Acta Pathol Microbiol Scand       Date:  1961

3.  Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria.

Authors:  L G Burman
Journal:  J Antimicrob Chemother       Date:  1977-09       Impact factor: 5.790

4.  Antibiotic resistance in Shigella mediated by R factors.

Authors:  W E Farrar; M Eidson
Journal:  J Infect Dis       Date:  1971-05       Impact factor: 5.226

5.  In-vitro sensitivity of Shigella sonnei to trimethoprim and sulphamethoxazole.

Authors:  K J Jarvis; G Scrimgeour
Journal:  J Med Microbiol       Date:  1970-08       Impact factor: 2.472

6.  Treatment of sonne dysentery.

Authors:  P J Moorhead; H E Parry
Journal:  Br Med J       Date:  1965-10-16

7.  Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974.

Authors:  P A Byers; H L Dupont; M C Goldschmidt
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

8.  Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis.

Authors:  M J Chang; L M Dunkle; D Van Reken; D Anderson; M L Wong; R D Feigin
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

  8 in total
  6 in total

1.  Plasmid-mediated drug resistance of shigellae in Kuwait.

Authors:  T D Chugh; A Suheir; A G Mahboob; L Neil; E el-Bishbishi
Journal:  Antonie Van Leeuwenhoek       Date:  1985       Impact factor: 2.271

Review 2.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 3.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

4.  Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis.

Authors:  I Kabir; M M Rahaman; S M Ahmed; S Q Akhter; T Butler
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

5.  The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Authors:  R Vanhoof; J M Hubrechts; E Roebben; H J Nyssen; E Nulens; J Leger; N De Schepper
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

6.  In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.

Authors:  D L Shungu; E Weinberg; H H Gadebusch
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.